COVID-19 Infection on IL-23 Inhibition

Dermatol Ther. 2020 Jun 25. doi: 10.1111/dth.13893. Online ahead of print.

Abstract

No abstract available

Keywords: COVID-19; IL-23; SARS-CoV-2; biologic; psoriasis; risankizumab.

Publication types

  • Letter